Pacific Biosciences of California Yönetim
Yönetim kriter kontrolleri 2/4
Pacific Biosciences of California CEO'su Christian O. Henry, Sep2020 tarihinde atandı, in görev süresi 4.17 yıldır. in toplam yıllık tazminatı $ 8.05M olup, şirket hissesi ve opsiyonları dahil olmak üzere 8.6% maaş ve 91.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.14% ine doğrudan sahiptir ve bu hisseler $ 668.18K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.2 yıl ve 11.8 yıldır.
Anahtar bilgiler
Christian O. Henry
İcra Kurulu Başkanı
US$8.0m
Toplam tazminat
CEO maaş yüzdesi | 8.6% |
CEO görev süresi | 4.2yrs |
CEO sahipliği | 0.1% |
Yönetim ortalama görev süresi | 4.2yrs |
Yönetim Kurulu ortalama görev süresi | 11.8yrs |
Son yönetim güncellemeleri
Recent updates
Pacific Biosciences' Cost Cuts Won't Offset Rising Competition
Nov 12Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company
Nov 07Health Check: How Prudently Does Pacific Biosciences of California (NASDAQ:PACB) Use Debt?
Oct 16Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely
Sep 20Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing
Aug 21Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper
Jul 02We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt
Jun 08Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas
Jun 03These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat
Apr 25It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks
Apr 16Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
Mar 19Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth
Feb 08With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For
Feb 01What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S
Dec 18Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?
Nov 13The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%
Aug 28Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?
Jul 31Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Jul 06Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt
May 25Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Mar 29Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?
Feb 26CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$394m |
Jun 30 2024 | n/a | n/a | -US$400m |
Mar 31 2024 | n/a | n/a | -US$297m |
Dec 31 2023 | US$8m | US$695k | -US$307m |
Sep 30 2023 | n/a | n/a | -US$309m |
Jun 30 2023 | n/a | n/a | -US$319m |
Mar 31 2023 | n/a | n/a | -US$321m |
Dec 31 2022 | US$7m | US$667k | -US$314m |
Sep 30 2022 | n/a | n/a | -US$299m |
Jun 30 2022 | n/a | n/a | -US$206m |
Mar 31 2022 | n/a | n/a | -US$175m |
Dec 31 2021 | US$3m | US$650k | -US$181m |
Sep 30 2021 | n/a | n/a | -US$37m |
Jun 30 2021 | n/a | n/a | -US$77m |
Mar 31 2021 | n/a | n/a | -US$59m |
Dec 31 2020 | US$13m | US$195k | US$29m |
Sep 30 2020 | n/a | n/a | -US$46m |
Jun 30 2020 | n/a | n/a | -US$51m |
Mar 31 2020 | n/a | n/a | -US$53m |
Dec 31 2019 | US$100k | n/a | -US$84m |
Sep 30 2019 | n/a | n/a | -US$115m |
Jun 30 2019 | n/a | n/a | -US$111m |
Mar 31 2019 | n/a | n/a | -US$109m |
Dec 31 2018 | US$88k | n/a | -US$103m |
Tazminat ve Piyasa: Christian O. 'nin toplam tazminatı ($USD 8.05M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 2.24M ).
Tazminat ve Kazançlar: Christian O. şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Christian O. Henry (56 yo)
4.2yrs
Görev süresi
US$8,046,575
Tazminat
Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 4.2yrs | US$8.05m | 0.14% $ 668.2k | |
Chief Financial Officer | 4.2yrs | US$2.52m | 0.043% $ 203.4k | |
Chief Operating Officer | 3.8yrs | US$4.60m | 0.12% $ 544.2k | |
Co-Founder | 24.3yrs | US$466.76k | Veri yok | |
VP & Chief Accounting Officer | 3.5yrs | Veri yok | 0.013% $ 62.3k | |
General Counsel & Corporate Secretary | no data | Veri yok | Veri yok | |
Chief People Officer | no data | Veri yok | Veri yok |
4.2yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim: PACB 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.2 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 6.3yrs | US$8.05m | 0.14% $ 668.2k | |
Independent Director | 20.8yrs | US$259.00k | 0.0069% $ 32.3k | |
Independent Director | 12.2yrs | US$255.00k | 0% $ 0 | |
Independent Chairman | 11.3yrs | US$297.00k | 0.040% $ 189.2k | |
Member of the Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of the Scientific Advisory Board | no data | Veri yok | Veri yok | |
Independent Director | 15.8yrs | US$265.00k | 0% $ 0 | |
Member of the Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of the Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of the Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of the Scientific Advisory Board | no data | Veri yok | Veri yok | |
Chairman of Scientific Advisory Board | 2yrs | Veri yok | Veri yok |
11.8yrs
Ortalama Görev Süresi
70yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: PACB 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11.8 yıldır).